Cargando…

Nanotechnology-based products for cancer immunotherapy

ABSTRACT: Currently, nanoscale materials and scaffolds carrying antitumor agents to the tumor target site are practical approaches for cancer treatment. Immunotherapy is a modern approach to cancer treatment in which the body’s immune system adjusts to deal with cancer cells. Immuno-engineering is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shams, Forough, Golchin, Ali, Azari, Arezo, Mohammadi Amirabad, Leila, Zarein, Fateme, Khosravi, Atiyeh, Ardeshirylajimi, Abdolreza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555726/
https://www.ncbi.nlm.nih.gov/pubmed/34716502
http://dx.doi.org/10.1007/s11033-021-06876-y
_version_ 1784592035314925568
author Shams, Forough
Golchin, Ali
Azari, Arezo
Mohammadi Amirabad, Leila
Zarein, Fateme
Khosravi, Atiyeh
Ardeshirylajimi, Abdolreza
author_facet Shams, Forough
Golchin, Ali
Azari, Arezo
Mohammadi Amirabad, Leila
Zarein, Fateme
Khosravi, Atiyeh
Ardeshirylajimi, Abdolreza
author_sort Shams, Forough
collection PubMed
description ABSTRACT: Currently, nanoscale materials and scaffolds carrying antitumor agents to the tumor target site are practical approaches for cancer treatment. Immunotherapy is a modern approach to cancer treatment in which the body’s immune system adjusts to deal with cancer cells. Immuno-engineering is a new branch of regenerative medicine-based therapies that uses engineering principles by using biological tools to stimulate the immune system. Therefore, this branch’s final aim is to regulate distribution, release, and simultaneous placement of several immune factors at the tumor site, so then upgrade the current treatment methods and subsequently improve the immune system’s handling. In this paper, recent research and prospects of nanotechnology-based cancer immunotherapy have been presented and discussed. Furthermore, different encouraging nanotechnology-based plans for targeting various innate and adaptive immune systems will also be discussed. Due to novel views in nanotechnology strategies, this field can address some biological obstacles, although studies are ongoing. GRAPHIC ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-8555726
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-85557262021-11-01 Nanotechnology-based products for cancer immunotherapy Shams, Forough Golchin, Ali Azari, Arezo Mohammadi Amirabad, Leila Zarein, Fateme Khosravi, Atiyeh Ardeshirylajimi, Abdolreza Mol Biol Rep Review ABSTRACT: Currently, nanoscale materials and scaffolds carrying antitumor agents to the tumor target site are practical approaches for cancer treatment. Immunotherapy is a modern approach to cancer treatment in which the body’s immune system adjusts to deal with cancer cells. Immuno-engineering is a new branch of regenerative medicine-based therapies that uses engineering principles by using biological tools to stimulate the immune system. Therefore, this branch’s final aim is to regulate distribution, release, and simultaneous placement of several immune factors at the tumor site, so then upgrade the current treatment methods and subsequently improve the immune system’s handling. In this paper, recent research and prospects of nanotechnology-based cancer immunotherapy have been presented and discussed. Furthermore, different encouraging nanotechnology-based plans for targeting various innate and adaptive immune systems will also be discussed. Due to novel views in nanotechnology strategies, this field can address some biological obstacles, although studies are ongoing. GRAPHIC ABSTRACT: [Image: see text] Springer Netherlands 2021-10-29 2022 /pmc/articles/PMC8555726/ /pubmed/34716502 http://dx.doi.org/10.1007/s11033-021-06876-y Text en © The Author(s), under exclusive licence to Springer Nature B.V. 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review
Shams, Forough
Golchin, Ali
Azari, Arezo
Mohammadi Amirabad, Leila
Zarein, Fateme
Khosravi, Atiyeh
Ardeshirylajimi, Abdolreza
Nanotechnology-based products for cancer immunotherapy
title Nanotechnology-based products for cancer immunotherapy
title_full Nanotechnology-based products for cancer immunotherapy
title_fullStr Nanotechnology-based products for cancer immunotherapy
title_full_unstemmed Nanotechnology-based products for cancer immunotherapy
title_short Nanotechnology-based products for cancer immunotherapy
title_sort nanotechnology-based products for cancer immunotherapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555726/
https://www.ncbi.nlm.nih.gov/pubmed/34716502
http://dx.doi.org/10.1007/s11033-021-06876-y
work_keys_str_mv AT shamsforough nanotechnologybasedproductsforcancerimmunotherapy
AT golchinali nanotechnologybasedproductsforcancerimmunotherapy
AT azariarezo nanotechnologybasedproductsforcancerimmunotherapy
AT mohammadiamirabadleila nanotechnologybasedproductsforcancerimmunotherapy
AT zareinfateme nanotechnologybasedproductsforcancerimmunotherapy
AT khosraviatiyeh nanotechnologybasedproductsforcancerimmunotherapy
AT ardeshirylajimiabdolreza nanotechnologybasedproductsforcancerimmunotherapy